FDA is issuing more postmarketing requirements, but challenges with oversight persist.
- Physical Description: 1 online resource (26 pages) : illustrations
- Publisher: [Washington, D.C.] : Department of Health and Human Services, Office of Inspector General, 2016.
|General Note:|| Title from title screen (viewed Aug 9, 2016).
|Bibliography, etc. Note:|| Includes bibliographical references.
Search for related items by subject
|Subject:||United States. Food and Drug Administration > Rules and practice.
Drugs > United States > Testing > Management.
Clinical trials > Government policy > United States.